British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a Massachusetts-based biopharmaceutical company, strengthening its position in the oncology sector. The FTSE
All posts tagged in Healthcare Innovation2- Page
25Articles
Shares in Oxford Nanopore Technologies jumped 8.9 per cent today after the British gene sequencing innovator reported robust revenue growth and reaffirmed its path to profitability. The FTSE 250 company
A groundbreaking series A funding round has positioned London-based Verdiva Bio at the forefront of the obesity treatment sector, securing an impressive $411 million investment. This remarkable achievement stands as
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
British officials are studying pricing models for NHS patient data as part of an ambitious scheme to streamline information sales to companies and researchers. The initiative forms a crucial component
Artificial intelligence is revolutionising pharmaceutical research, offering groundbreaking opportunities for drug discovery whilst potentially saving billions in development costs. Leading pharmaceutical giants GSK and AstraZeneca are at the forefront of
A revolutionary combination of three drugs has demonstrated remarkable success in doubling survival times for patients battling incurable breast cancer, according to a landmark clinical trial. The research, spearheaded by
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy,
The landscape of vaccine technology is witnessing a revolutionary change with the introduction of TNX-1800, a next-generation COVID-19 vaccine developed by Tonix Pharmaceuticals. Led by CEO Dr. Seth Lederman, the
- 1
- 2
